BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37344705)

  • 1. Anthracycline chemicals with anthracyclinone structure exert antitumor effects by inhibiting angiogenesis and lymphangiogenesis in a xenografted gastric tumor model.
    Li H; Jia C; Li C; Wang Y; Du W; Jiang H
    Gastric Cancer; 2023 Nov; 26(6):863-877. PubMed ID: 37344705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
    Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
    Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor effect of angiogenesis inhibitor TNP-470 and 5-FU combined therapy on human gastric cancer xenograft.
    Nishimura K; Ohno M; Chung-Kang C; Kuroda Y
    Hepatogastroenterology; 2008; 55(82-83):774-8. PubMed ID: 18613452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis.
    Pak KH; Park KC; Cheong JH
    BMC Cancer; 2019 Aug; 19(1):799. PubMed ID: 31409309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel and 5-FU enhanced the inhibitory effects of apatinib and ramucirumab on growth and migration of gastric cancer.
    Wu JQ; Fan RY; Zhai J; Li CY; Wei P; Shen LZ; He MF; Wang P; Huang XE
    Life Sci; 2022 May; 296():120439. PubMed ID: 35235851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin Exerts Antitumor Effects by Inhibiting Angiogenesis in a HT29 Human Colon Tumor Model.
    Li HY; Li M; Luo CC; Wang JQ; Zheng N
    J Agric Food Chem; 2017 Dec; 65(48):10464-10472. PubMed ID: 29112400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
    Li H; Adachi Y; Yamamoto H; Min Y; Ohashi H; Ii M; Arimura Y; Endo T; Lee CT; Carbone DP; Imai K; Shinomura Y
    Cancer; 2011 Jul; 117(14):3135-47. PubMed ID: 21264842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies.
    Zhao L; Chen H; Lu L; Wang L; Zhang X; Guo X
    J Drug Target; 2021 Feb; 29(2):155-167. PubMed ID: 32838575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mineral dust-induced gene,
    Zhou H; Geng F; Chen Y; Du J; Zhang X; Liu B; Song D; Hou H; Zhao H
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
    Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
    Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
    Zhang L; Kim S; Ding W; Tong Y; Zhang X; Pan M; Chen S
    Drug Des Devel Ther; 2015; 9():5579-90. PubMed ID: 26487802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages induce capillary morphogenesis of lymphatic endothelial cells derived from human gastric cancer.
    Tauchi Y; Tanaka H; Kumamoto K; Tokumoto M; Sakimura C; Sakurai K; Kimura K; Toyokawa T; Amano R; Kubo N; Muguruma K; Yashiro M; Maeda K; Ohira M; Hirakawa K
    Cancer Sci; 2016 Aug; 107(8):1101-9. PubMed ID: 27227358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.
    Ma C; Yin H; Zhong J; Zhang Y; Luo C; Che D; Fang Z; Li L; Qin S; Liang J; Qi W; Yang Z; Zhou T; Ma J; Yang X; Gao G
    Int J Oncol; 2017 Jun; 50(6):2000-2010. PubMed ID: 28440474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF‑C expression and secretion.
    Ma C; Xie J; Luo C; Yin H; Li R; Wang X; Xiong W; Zhang T; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
    Int J Oncol; 2019 Feb; 54(2):572-584. PubMed ID: 30483757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
    Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
    Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Difference of gene expression profile in human gastric cancer grafted onto nude mice treated with WCA].
    Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2028-36. PubMed ID: 18161298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
    Xu GY; Tang XJ
    Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.